Novozymes A/S’ stock buyback program completed

Novozymes has now completed the announced DKK 2 billion share buyback program.

As of December 10, Novozymes has purchased an accumulated 7,734,631 shares with a transaction value of DKK 2,000 million under the stock buyback program Novozymes announced in Company announcement No. 17, 2014 and initiated February 17, 2014.
The following transactions have been made under the program in accordance with the provisions of European Commission Regulation (EC) No. 2273/2003 of 22 December 2003, also referred to as the Safe Harbour Regulation:
       
 
Number
 of shares
Average
purchase price
Transaction
value, DKK
Accumulated, last announcement
7,588,696
 
1,960,765,725
December 5, 2014
36,000
269.23
9,692,182
December 8, 2014
36,000
271.21
9,763,480
December 9, 2014
36,000
267.40
9,626,286
December 10, 2014
37,935
 267.54
10,149,011
Total accumulated under the program
7,734,631
 
1,999,996,684
 
In addition, transactions necessitated by Novozymes’ previously established incentive programs have resulted in a net sale by Novozymes of 6,417 B shares in the period from December 5 to December 10, 2014. The share transactions related to the incentive programs were not part of the Safe Harbour stock buyback program.
 
Following the transactions stated above, Novozymes owns a total of 11,507,113 treasury shares, corresponding to 3.6% of the stock capital. The total number of shares in the company is 319,700,000, including treasury shares.

Contact information

Investor Relations:
 
 
Thomas Bomhoff (DK)
+45 3077 1226
Klaus Sindahl (DK)
+45 5363 0134
Martin Riise (USA)
+1 919 649 2565
Media Relations:
 
 
Rene Tronborg (DK)
+45 3077 2274
Frederik Bjoerndal (Europe)
+44 7976138265
Paige Donnelly (USA)
+1 919 218 4501
Henrique Pellini (Brazil)
+55 41 9288 0282